Home The Word Brain	My Amedeo FAQ Privacy About
	C49 + CC Journal Club For more information, please refer to our special emails from April 13 and May 19.

Liver Cirrhosis

Free Subscription 21.04.2025 3 BMC Gastroenterol 2 Hepatology 2 Intern Med 7 J Hepatol

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

BMC Gastroenterol

1. MOON SY, Son M, Kang YW, Koh M, et al
   Associations between non-insulin-based insulin resistance surrogate markers and liver-related outcomes in metabolic dysfunction-associated steatotic liver disease: a nationwide cohort study in South Korea.
   BMC Gastroenterol. 2025;25:274.
   PubMed         Abstract available
   
   
2. GUO Y, Su W, Tao L, Zhang G, et al
   The association between modified cardiometabolic index with non-alcoholic fatty liver disease and liver fibrosis: a cross-sectional study.
   BMC Gastroenterol. 2025;25:265.
   PubMed         Abstract available
   
   
3. ZHOU Y, Lin H, Weng X, Dai H, et al
   Correlation between hs-CRP-triglyceride glucose index and NAFLD and liver fibrosis.
   BMC Gastroenterol. 2025;25:252.
   PubMed         Abstract available
   
   

   
   Hepatology

4. HOLMER M, Ingre M, Farkkila M, Ponsioen C, et al
   Cirrhosis and age are key determinants of HCC risk in individuals with primary sclerosing cholangitis: A multicenter longitudinal cohort study.
   Hepatology. 2025 Apr 16. doi: 10.1097/HEP.0000000000001351.
   PubMed         Abstract available
   
   
5. LUCAS MR, Pilling LC, Atkins JL, Melzer D, et al
   Incidence of liver complications with hemochromatosis associated HFE p.C282Y homozygosity: The role of central adiposity.
   Hepatology. 2024 Aug 23. doi: 10.1097/HEP.0000000000001056.
   PubMed         Abstract available
   
   

   
   Intern Med

6. AMANO K, Sano T, Ide T, Nakano D, et al
   The Effect of MAFLD on Hepatocarcinogenesis in HBeAg-negative Patients with Undetectable HBV-DNA under NA Therapy: A Multicenter Study.
   Intern Med. 2025;64:1133-1141.
   PubMed         Abstract available
   
   
7. OEDA S, Inoue K, Isoda H, Hirai K, et al
   Survey on Awareness and Implementation Rate of Ultrasound Elastography and Attenuation Imaging.
   Intern Med. 2025;64:1143-1149.
   PubMed         Abstract available
   
   

   
   J Hepatol

8. REIBERGER T, Maasoumy B
   Advancing our understanding of recompensated cirrhosis - the new "holy grail" of decompensated cirrhosis.
   J Hepatol. 2025 Apr 16:S0168-8278(25)00241-7. doi: 10.1016/j.jhep.2025.
   PubMed        
   
   
9. TONON M, Gagliardi R, Pompili E, Barone A, et al
   Validation and expansion of Baveno VII recompensation criteria in patients with cirrhosis and curable liver disease.
   J Hepatol. 2025 Apr 12:S0168-8278(25)00245-4. doi: 10.1016/j.jhep.2025.
   PubMed         Abstract available
   
   
10. NAIK I, Yeo YH, Ng WH, Sheng-Kai Ma K, et al
    Carvedilol is Associated with Lower Risk of Hepatic Decompensation Compared to Other Non-Selective Beta-Blockers in Cirrhosis.
    J Hepatol. 2025 Apr 11:S0168-8278(25)00232-6. doi: 10.1016/j.jhep.2025.
    PubMed        
    
    
11. SUN SS, Zhang J, Jin YP, Li L, et al
    A Rare Cause of Lipid Metabolism Disorder and Cirrhosis in an Adult.
    J Hepatol. 2025 Apr 9:S0168-8278(25)00227-2. doi: 10.1016/j.jhep.2025.
    PubMed        
    
    
12. CALES P, Canivet CM, Costentin C, Lannes A, et al
    A new generation of non-invasive tests of liver fibrosis with improved accuracy in MASLD.
    J Hepatol. 2025;82:794-804.
    PubMed         Abstract available
    
    
13. ABDURRACHIM D, Lek S, Ong CZL, Wong CK, et al
    Utility of AI digital pathology as an aid for pathologists scoring fibrosis in MASH.
    J Hepatol. 2025;82:898-908.
    PubMed         Abstract available
    
    
14. KIM HY, Rosenthal SB, Liu X, Miciano C, et al
    Multi-Modal Analysis of human Hepatic Stellate Cells identifies novel therapeutic targets for Metabolic Dysfunction-Associated Steatotic Liver Disease.
    J Hepatol. 2024 Nov 8:S0168-8278(24)02667-9. doi: 10.1016/j.jhep.2024.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Liver Cirrhosis is free of charge.